Experience

DualityBio Announces HK$1.64 Billion IPO

April 24, 2025

Cooley advised the underwriters of Duality Biologics (DualityBio), a clinical-stage biotech company focused on the discovery and development of next-generation antibody-drug conjugate therapeutics for patients with cancer and autoimmune diseases, in connection with its HK$1.64 billion global initial public offering (IPO).

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Santa Monica
Vince Sampson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Monica Xu
Special Counsel, Shanghai
Hilda Li
Associate, Hong Kong
Zixiang Liu
Associate, Shanghai
Patrick Sharma
Associate, Santa Monica
Yiying Wang
Associate, Shanghai
Yunxiang Xu
Associate, Shanghai
Kaiting Yang
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Letian Wei
Legal Consultant, Shanghai
Cindy Pan
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

Zenergy Announces HK$1 Billion IPO

April 14, 2025

Cooley advised the sponsors and underwriters of Jiangsu Zenergy Battery Technologies Group (Zenergy) – a lithium-ion battery manufacturer focusing on the research and development, production and sales of electric vehicle battery products, electrochemical energy storage battery products and aviation battery products – in connection with Zenergy’s HK$1 billion global initial public offering.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Will Cai
Partner, Hong Kong
Kaiting Yang
Associate, Hong Kong
Yiying Wang
Associate, Shanghai
Dichun Duan
Associate, Beijing
April Wang
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai

Related Practices & Industries

VISEN Pharmaceuticals Announces HK$783 Million IPO

March 21, 2025

Cooley advised VISEN Pharmaceuticals, a late-stage, near-commercialization biopharmaceutical company focused on providing treatments for select endocrine diseases in Greater China (including Hong Kong, Macau and Taiwan), on its HK$783 million (approximately US$101 million) initial public offering (IPO) on the Stock Exchange of Hong Kong, subject to the exercise of a 15% overallotment option.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Will Cai
Partner, Hong Kong
Annie Froehlich
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Hilda Li
Associate, Hong Kong
Ying Liu
Associate, Hong Kong
Amanda Pacheco
Associate, Palo Alto
Hardy Zhou
Associate, New York
Alex Wu
Associate, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Kaiting Yang
Associate, Hong Kong

Related Practices & Industries

Harbour BioMed Announces $105.3 Million Share Subscription Agreement With AstraZeneca

March 21, 2025

Cooley advised Harbour BioMed (HBM Holdings, HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in oncology and immunology, on its share subscription agreement with AstraZeneca.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Kaiting Yang
Associate, Hong Kong
Ying Liu
Associate, Hong Kong
Cindy Pan
International Legal Project Manager, Hong Kong

Related Practices & Industries

BrainAurora Medical Technology – HK$583 Million IPO

January 8, 2025

Cooley advised the sponsors and underwriters of BrainAurora Medical Technology, a provider of medical diagnostics and digital therapies, in connection with the company’s HK$583 million initial public offering.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Kaiting Yang
Associate, Hong Kong
Yiying Wang
Associate, Shanghai
April Wang
Associate, Hong Kong
Zhengyang Li
International Legal Project Manager, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

View more

Admissions and credentials

Solicitor of Hong Kong

New York